Restricted accessResearch articleFirst published online 2023-2
Assessing depressive symptoms and diabetes distress in Type 1 diabetic adults: A comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) users
This cross-sectional observational study assesses differences in depressive symptoms and diabetes-distress between adults with type 1 diabetes using continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI) insulin delivery methods. Two-hundred and seventy-one adults with type 1 diabetes were recruited who used CSII (n = 104) or MDI (n = 167). Results show that, compared to CSII users, scores on the Severity Measure for Depression – Adult questionnaire and Management and Physician subscales on the Type 1 Diabetes Distress Scale were significantly greater in users of MDI. Thus, MDI users may require greater targetted support to improve these aspects of psychological wellbeing.
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn.Washington, DC: American Psychiatric Association.
2.
AndersonRJFreedlandKEClouseRE, et al (2001) The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care24(6): 1069–1078.
BaekRNTanenbaumMLGonzalezJS (2014) Diabetes burden and diabetes distress: The buffering effect of social support. Annals of Behavioral Medicine48(2): 145–155.
5.
BalfeMDoyleFSmithD, et al (2013) What’s distressing about having type 1 diabetes? A qualitative study of young adults’ perspectives. BMC Endocrine Disorders13(1): 25.
6.
BarnardKDSkinnerTCPevelerR (2006) The prevalence of co-morbid depression in adults with Type 1 diabetes: Systematic literature review. Diabetic Medicine23(4): 445–448.
7.
BenedictCHahnALDiefenbachMA, et al (2019) Recruitment via social media: Advantages and potential biases. Digital Health5: 2055207619867223.
BodeBWSabbahHTGrossTM, et al (2002) Diabetes management in the new millennium using insulin pump therapy. Diabetes/Metabolism Research and Reviews18(S1): S14–S20.
10.
ChaturvediNStephensonJMFullerJH (1996) The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM Complications Study. Diabetes Care19(5): 423–430.
11.
CiechanowskiPSKatonWJRussoJE (2000) Depression and diabetes: Impact of depressive symptoms on adherence, function, and costs. Archive of Internal Medicine160(21): 3278–3285.
12.
CohenJ (1988) Statistical Power Analysis for the Behavioral Sciences, 2nd edn.New York: Academic Press.
13.
DaleyA (2008) Exercise and depression: A review of reviews. Journal of Clinical Psychology in Medical Settings15(2): 140–147.
14.
de GrootMAndersonRFreedlandKE, et al (2001) Association of depression and diabetes complications: A meta-analysis. Psychosomatic Medicine63(4): 619–630.
DucatLPhilipsonLHAndersonBJ (2014) The mental health comorbidities of diabetes. The Journal of the American Medical Association312(7): 691–692.
17.
DunnALJewellJS (2010) The effect of exercise on mental health. Current Sports Medicine Reports9(4): 202–207.
18.
EngumA (2007) The role of depression and anxiety in onset of diabetes in a large population-based study. Journal of Psychosomatic Research62(1): 31–38.
19.
FaulFErdfelderELangA-G, et al. (2007) G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods39(2): 175–191.
20.
FisherLHesslerDPolonskyW, et al (2016a) Diabetes distress in adults with type 1 diabetes: Prevalence, incidence and change over time. Journal of Diabetes and Its Complications30(6): 1123–1128.
21.
FisherLHesslerDMPolonskyWH, et al (2016b) Prevalence of depression in Type 1 diabetes and the problem of over-diagnosis. Diabetic Medicine33(11): 1590–1597.
22.
FisherLGonzalezJSPolonskyWH (2014) The confusing tale of depression and distress in patients with diabetes: A call for greater clarity and precision. Diabetic Medicine31(7): 764–772.
23.
FisherLPolonskyWHHesslerDM, et al (2015) Understanding the sources of diabetes distress in adults with type 1 diabetes. Journal of Diabetes and Its Complications29(4): 572–577.
24.
HanawiSASaatNZMZulkaflyM, et al (2020) Impact of a healthy lifestyle on the psychological well-being of university students. International Journal of Pharmaceutical Research & Allied Sciences9(2): 1–7.
25.
HoltRIPhillipsDIJamesonKA, et al; & Hertfordshire Cohort Study Group (2009) The relationship between depression and diabetes mellitus: Findings from the Hertfordshire Cohort Study. Diabetic Medicine26(6): 641–648.
26.
HoltRIGDeVriesJHHess-FischlA, et al (2021) The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care44(11): 2589–2625.
27.
HoogmaRPLHoekstraJBMichelsBP, et al (2006) Comparison between multiple daily insulin injection therapy (MDI) and continuous subcutaneous insulin infusion therapy (CSII), results of the five nations study. Diabetes Research and Clinical Practice74: S144–S147.
28.
KroenkeKSpitzerRLWilliamsJB (2001) The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine16(9): 606–613.
29.
KubiakTPriesterrothLBarnard-KellyKD (2020) Psychosocial aspects of diabetes technology. Diabetic Medicine37(3): 448–454.
30.
LittlefieldCHCravenJLRodinGM, et al (1992) Relationship of self-efficacy and binging to adherence to diabetes regimen among adolescents. Diabetes Care15(1): 90–94.
31.
LittonJRiceAFriedmanN, et al (2002) Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. The Journal of Pediatrics141(4): 490–495.
32.
LudmanEJKatonWRussoJ, et al (2004) Depression and diabetes symptom burden. General Hospital Psychiatry26(6): 430–436.
33.
MariaMDFabriziDLucianiM, et al. (2021) Further evidence of psychometric performance of the self-care of diabetes inventory in adults with Type 1 and Type 2 diabetes. Annals of Behavioral Medicine 29;56(6): 632–644.
34.
MianowskaBFedorczakAMichalakA, et al (2021) Diabetes related distress in children with type 1 diabetes before and during the COVID-19 Lockdown in Spring 2020. International Journal of Environmental Research and Public Health18(16): 8527.
35.
National Institute for Health and Care Excellence (2022) Type 1 diabetes in adults: Diagnosis and management. NICE Guideline [NG17], 31 March. Available at: https://www.nice.org.uk/guidance/ng17/chapter/Recommendations (accessed 14 April 2022).
OnderGRezzaGBrusaferroS (2020) Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. The Journal of the American Medical Association323(18): 1775–1776.
39.
PanditAUBaileySCCurtisLM, et al (2014) Disease-related distress, self-care and clinical outcomes among low-income patients with diabetes. Journal of Epidemiology and Community Health68(6): 557–564.
40.
ParkMKatonWJWolfFM (2013) Depression and risk of mortality in individuals with diabetes: A meta-analysis and systematic review. General Hospital Psychiatry35(3): 217–225.
41.
PeyrotMEgedeLECamposC, et al (2014) Ethnic differences in psychological outcomes among people with diabetes: USA results from the second Diabetes Attitudes, Wishes, and Needs (DAWN2) study. Current Medical Research and Opinion30(11): 2241–2254.
42.
PickupJMattockMKerryS (2002) Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: Meta-analysis of randomised controlled trials. BMJ324(7339): 705.
43.
PolonskyWHFisherLEarlesJ, et al (2005) Assessing psychosocial distress in diabetes: Development of the diabetes distress scale. Diabetes Care28(3): 626–631.
44.
PolonskyWHHesslerDRuedyKJ, et al (2017) The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes: Further findings from the DIAMOND randomized clinical trial. Diabetes Care40(6): 736–741.
45.
ReddyJWilhelmKCampbellL (2013) Putting PAID to diabetes-related distress: The potential utility of the problem areas in diabetes (PAID) scale in patients with diabetes. Psychosomatics54(1): 44–51.
46.
RheinheimerDCPenfieldDA (2001) The effects of Type I error rate and power of the ANCOVAFTest and selected alternatives under nonnormality and variance heterogeneity. Journal of Experiential Education69(4): 373–391.
47.
RobinsonDJCoonsMHaenselH, et al (2018) Diabetes and mental health. Canadian Journal of Diabetes42(Suppl. 1): S130–S141.
48.
RodriguesIASReidHAIsmailK, et al (2005) Indications and efficacy of continuous subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: A clinical audit in a specialist service. Diabetic Medicine22(7): 842–849.
49.
RubinRRPeyrotM (1999) Quality of life and diabetes. Diabetes/Metabolism Research and Reviews15(3): 205–218.
50.
SaarinenTFernströmLBrorssonAL, et al (2014) Insulin pump therapy is perceived as liberating, but to many it can imply a sense of the diabetes made visible. European Diabetes Nursing11(2): 38–42.
51.
SartoriusN (2018) Depression and diabetes. Dialogues in Clinical Neuroscience20(1): 47–52.
52.
SkinnerTCJoensenLParkinT (2020) Twenty-five years of diabetes distress research. Diabetic Medicine37(3): 393–400.
53.
SmithB (2013) Depression and motivation. Phenomenology and the Cognitive Sciences12(4): 615–635.
54.
SnoekFJPouwerFWelchGW, et al (2000) Diabetes-related emotional distress in Dutch and US diabetic patients: Cross-cultural validity of the problem areas in diabetes scale. Diabetes Care23(9): 1305–1309.
55.
StoneJYBaileyTS (2020) Benefits and limitations of continuous glucose monitoring in type 1 diabetes. Expert Review of Endocrinology & Metabolism15(1): 41–49.
56.
TodresLKeenSKerrD (2010) Continuous subcutaneous insulin infusion in Type 1 diabetes: Patient experiences of ‘living with a machine’. Diabetic Medicine27(10): 1201–1204.
57.
von ElmEAltmanDGEggerM, et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Bulletin of the World Health Organization85: 867–872.
WardianJLTrueMWFolaronI, et al (2020) The coice should be yours: Diabetes-related distress by insulin delivery method for people with type 1 diabetes. Diabetes Technology & Therapeutics22(1): 42–47.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
